The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
Here's a roundup of top developments in the biotech space over the last 24 hours:
Aadi Bioscience To Present New Preclinical Data On Nab-Sirolimus At AACR-NCI-EORTC Virtual International Conference
Aadi Bioscience, Inc. ("Aadi") (NASDAQ:AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced
Cowen & Co. Initiates Coverage On Aadi Bioscience with Outperform Rating
Cowen & Co. analyst Boris Peaker initiates coverage on Aadi Bioscience (NASDAQ:AADI) with a Outperform rating.
Ladenburg Thalmann Initiates Coverage On Aadi Bioscience with Buy Rating, Announces Price Target of $51
Ladenburg Thalmann initiates coverage on Aadi Bioscience (NASDAQ:AADI) with a Buy rating and announces Price Target of $51.
Piper Sandler Initiates Coverage On Aadi Bioscience with Overweight Rating, Announces Price Target of $45
Piper Sandler analyst Joseph Catanzaro initiates coverage on Aadi Bioscience (NASDAQ:AADI) with a Overweight rating and announces Price Target of $45.
HC Wainwright & Co. Maintains Buy on Aadi Biosciences, Inc. – Common Stock, Raises Price Target to $47
HC Wainwright & Co. analyst Robert Burns maintains Aadi Biosciences, Inc. - Common Stock (NASDAQ:AADI) with a Buy and raises the price target from $22 to $47.
60 Biggest Movers From Friday
Gainers
Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share.